Back to results
US 2017/0226139 A1Published application
Crystalline salts of (z)-o-octadec-9-en-1-yl o,o-dihydrogen phosphorothioate
AssigneeRxBio, Inc.
InventorsRama Krishna Reddy Singidi, Veeresh Gududuru, Mahmoud Mirmehrabi, Karin Emmons Thompson, Gabor Jozsef Tigyi, Charles Ryan Yates, Jurriaan Strobos
Life of this patent
Estimating the term…
Abstract
Here provided are a salt of Z)—O-octadec-9-en-1-yl O,O-dihydrogen phosphorothioate with an L-lysine addition in crystalline form and methods of making and using the same.
Claims20
A method for producing Rx100.L-lysine crystalline salts, comprising the steps of:
- a. mixing Rx100 free acid with L-lysine;
- and
- b. allowing the Rx100.L-Lysine salt to form in the presence of a suitable amount of a solvent.
A method for producing a (Z)—O-octadec-9-en-1-yl O,O-dihydrogen phosphorothioate free acid, comprising the steps of:
- a. mixing a thiophosphoryl chloride (PSCl3) with oleyl alcohol in a reaction that also include a base and a solvent to obtain an intermediate O—(Z)-oleyl dichloridothiophosphate;
- and
- b. allowing a hydrolysis reaction of the intermediate O—(Z)-oleyl dichloridothiophosphate to form (Z)—O-octadec-9-en-1-yl O,O-dihydrogen phosphorothioate free acid.
Dependencies are inferred from the claim text.